Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy

GM-CSF/CD40L vaccine and checkpoint inhibitor combination therapy

US Patent 10995140 · Granted May 4, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variant survivin vaccine for treatment of myeloma2025
Oncolytic virus or antigen presenting cell mediated cancer therapy using type I 2025
Variant survivin vaccine for treatment of myeloma2021
Combination immunotherapy for treating cancer2021
Conjugates for immunotherapy2019
Double mutant survivin vaccine2019
P53 vaccines for the treatment of cancers2014